Trial intelligence / Profile preview

Switch from cyclosporine to tacrolimus extended-release in renal transplant recipients

ChiCTR-ONC-10001519Phase 4Completed

Sponsor
People's Liberation Army
Start
Nov 2010
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of tacrolimus, sponsored by People's Liberation Army. Primary endpoint: Serum creatinine level. Started Nov 2010; status: completed.

02

Drugs

tacrolimus

Beyond the preview

Go deeper on ChiCTR-ONC-10001519.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-ONC-10001519.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call